Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity

Georgios Paraskevopoulos; Martin Krátký; Jana Mandíková; František Trejtnar; Jiřina Stolaříková; Petr Pávek; Gurdyal Besra; Jarmila Vinšová

doi:10.1016/j.bmc.2015.10.029

Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity

Georgios Paraskevopoulos, Martin Krátký, Jana Mandíková, František Trejtnar, Jiřina Stolaříková, Petr Pávek, Gurdyal Besra, Jarmila Vinšová

Biosciences

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

254 Downloads (Pure)

Abstract

Inspired by the high antituberculous activity of novel nitro-substituted derivatives and based on promising predicted ADMET properties we have synthesized a series of 33 salicylanilides containing nitro-group in their salicylic part and evaluated them for their in vitro antimycobacterial, antimicrobial and antifungal activities. The presence of nitro-group in position 4 of the salicylic acid was found to be beneficial and the resulting molecules exhibited minimum inhibitory concentrations (MICs) ranging from 2 to 32μM against Mycobacterium tuberculosis. The best activity was found for 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide (MIC=2μM). 4-Nitrosalicylanilides were also found to be active against all Staphylococcus species tested while for MRSA strain 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide's MIC was 0.98μM. None of the nitrosalicylanilides was active against Enterococcus sp. J 14365/08 and no considerable activity was found against Gram-negative bacteria or fungi. The hepatotoxicity of all nitrosalicylanilides was found to be in the range of their MICs for HepG2 cells.

Original language	English
Pages (from-to)	7292-301
Number of pages	10
Journal	Bioorganic & Medicinal Chemistry
Volume	23
Issue number	22
Early online date	24 Oct 2015
DOIs	https://doi.org/10.1016/j.bmc.2015.10.029
Publication status	Published - 15 Nov 2015

Keywords

Salicylanilides
Nitro group
In silico ADMET prediction
In vitro antimycobacterial activity
Cytotoxicity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bmc.2015.10.029

Paraskevopoulos_et_al_Novel_derivatives_of_nitro_substituted_Bioorganic_Medicinal_Chemistry_2015_PostPrint
After an embargo period this document is subject to the terms of a Creative Attribution Non-Commercial No Derivatives license Checked Jan 2016
Accepted author manuscript, 590 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{2a8deacdf0114d339f0eae238b42ada0,

title = "Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity",

abstract = "Inspired by the high antituberculous activity of novel nitro-substituted derivatives and based on promising predicted ADMET properties we have synthesized a series of 33 salicylanilides containing nitro-group in their salicylic part and evaluated them for their in vitro antimycobacterial, antimicrobial and antifungal activities. The presence of nitro-group in position 4 of the salicylic acid was found to be beneficial and the resulting molecules exhibited minimum inhibitory concentrations (MICs) ranging from 2 to 32μM against Mycobacterium tuberculosis. The best activity was found for 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide (MIC=2μM). 4-Nitrosalicylanilides were also found to be active against all Staphylococcus species tested while for MRSA strain 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide's MIC was 0.98μM. None of the nitrosalicylanilides was active against Enterococcus sp. J 14365/08 and no considerable activity was found against Gram-negative bacteria or fungi. The hepatotoxicity of all nitrosalicylanilides was found to be in the range of their MICs for HepG2 cells.",

keywords = "Salicylanilides, Nitro group, In silico ADMET prediction, In vitro antimycobacterial activity, Cytotoxicity",

author = "Georgios Paraskevopoulos and Martin Kr{\'a}tk{\'y} and Jana Mand{\'i}kov{\'a} and Franti{\v s}ek Trejtnar and Ji{\v r}ina Stola{\v r}{\'i}kov{\'a} and Petr P{\'a}vek and Gurdyal Besra and Jarmila Vin{\v s}ov{\'a}",

year = "2015",

month = nov,

day = "15",

doi = "10.1016/j.bmc.2015.10.029",

language = "English",

volume = "23",

pages = "7292--301",

journal = "Bioorganic & Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier",

number = "22",

}

TY - JOUR

T1 - Novel derivatives of nitro-substituted salicylic acids

T2 - Synthesis, antimicrobial activity and cytotoxicity

AU - Paraskevopoulos, Georgios

AU - Krátký, Martin

AU - Mandíková, Jana

AU - Trejtnar, František

AU - Stolaříková, Jiřina

AU - Pávek, Petr

AU - Besra, Gurdyal

AU - Vinšová, Jarmila

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Inspired by the high antituberculous activity of novel nitro-substituted derivatives and based on promising predicted ADMET properties we have synthesized a series of 33 salicylanilides containing nitro-group in their salicylic part and evaluated them for their in vitro antimycobacterial, antimicrobial and antifungal activities. The presence of nitro-group in position 4 of the salicylic acid was found to be beneficial and the resulting molecules exhibited minimum inhibitory concentrations (MICs) ranging from 2 to 32μM against Mycobacterium tuberculosis. The best activity was found for 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide (MIC=2μM). 4-Nitrosalicylanilides were also found to be active against all Staphylococcus species tested while for MRSA strain 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide's MIC was 0.98μM. None of the nitrosalicylanilides was active against Enterococcus sp. J 14365/08 and no considerable activity was found against Gram-negative bacteria or fungi. The hepatotoxicity of all nitrosalicylanilides was found to be in the range of their MICs for HepG2 cells.

AB - Inspired by the high antituberculous activity of novel nitro-substituted derivatives and based on promising predicted ADMET properties we have synthesized a series of 33 salicylanilides containing nitro-group in their salicylic part and evaluated them for their in vitro antimycobacterial, antimicrobial and antifungal activities. The presence of nitro-group in position 4 of the salicylic acid was found to be beneficial and the resulting molecules exhibited minimum inhibitory concentrations (MICs) ranging from 2 to 32μM against Mycobacterium tuberculosis. The best activity was found for 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide (MIC=2μM). 4-Nitrosalicylanilides were also found to be active against all Staphylococcus species tested while for MRSA strain 2-hydroxy-4-nitro-N-[4-(trifluoromethyl)phenyl]benzamide's MIC was 0.98μM. None of the nitrosalicylanilides was active against Enterococcus sp. J 14365/08 and no considerable activity was found against Gram-negative bacteria or fungi. The hepatotoxicity of all nitrosalicylanilides was found to be in the range of their MICs for HepG2 cells.

KW - Salicylanilides

KW - Nitro group

KW - In silico ADMET prediction

KW - In vitro antimycobacterial activity

KW - Cytotoxicity

U2 - 10.1016/j.bmc.2015.10.029

DO - 10.1016/j.bmc.2015.10.029

M3 - Article

C2 - 26526729

SN - 0968-0896

VL - 23

SP - 7292

EP - 7301

JO - Bioorganic & Medicinal Chemistry

JF - Bioorganic & Medicinal Chemistry

IS - 22

ER -

Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this